• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec5
Xenon Pharmaceuticals Announces 48-Month Study Results for Azetukalner in Refractory Epilepsy
14:00
Nov25
Xenon Pharmaceuticals to Present New Clinical Data on Azetukalner at AES 2025
13:30
Nov6
Wedbush Analyst Cuts Xenon Pharmaceuticals FY2029 EPS Estimate
14:17
Nov5
Xenon Pharmaceuticals Highlights Optimism from Clinical Progress and Financial Status
00:57
Nov4
Gerberry Recommends Healthcare Stocks; H.C. Wainwright Reiterates Xenon Buy Rating
15:08
Xenon Pharma released FY2025 9 Months Earnings on November 3 After-Market EST, Actual Revenue: USD 7.5 M, Actual EPS: USD -3.0495
00:00

Schedules & Filings

Schedules
Filings
Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -90.9 M, EPS -1.1469

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -84.71 M, EPS -1.0728

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 7.5 M, Net Income -65.05 M, EPS -0.8266

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AMCI
7.270
+168.27%
+4.560
RADX
10.630
+149.53%
+6.370
ARTV
6.300
+90.91%
+3.000
NTCL
0.9500
+39.71%
+0.270
MASK
0.4100
+36.35%
+0.109
QIPT
3.500
+34.10%
+0.890
KXIN
4.440
+33.73%
+1.120
ASTI
4.170
+33.65%
+1.050
CLIK
7.200
+28.34%
+1.590
CLYM
3.810
+27.00%
+0.810
View More